Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enzo Biochem, Inc. Common Stock ($0.01 Par Value) (NY:ENZ)

0.3138 -0.0678 (-17.77%)
Official Closing Price Updated: 7:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

< Previous 1 2 3 4 Next >
Enzo Biochem Reports Third Quarter Fiscal Year 2023 Financial Results
From Enzo Biochem, Inc.
Via GlobeNewswire
Federman & Sherwood Investigates Enzo Biochem for Data Breach
From Federman & Sherwood
Via Business Wire
Enzo Biochem Reports Significant Progress towards Completing the Clinical Lab Asset Sale
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem (NYSE: ENZ) Leading the Way in Friday Trading Based on Percentage Gain
Via Investor Brand Network
Why Is Histogen (HSTO) Stock Up 37% Today?
Histogen (HSTO) stock is rising higher on Friday after getting a patent for CTS-2090 that protects its products through 2040. 
Via InvestorPlace
Why Is Enzo Biochem (ENZ) Stock Up 72% Today?
Enzo Biochem (ENZ) stock is rocketing higher on Friday with heavy trading after the company agreed to an asset sale with Labcorp (LH). 
Via InvestorPlace
Enzo Biochem, Inc. Announces Date of Special Meeting of Shareholders
From Enzo Biochem, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Enzo Biochem Reports Second Quarter Fiscal Year 2023 Financial Results
From Enzo Biochem, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Enzo Biochem, Inc. (NYSE: ENZ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp. 
Via Benzinga
Crude Oil Down 2%; Enzo Biochem Shares Spike Higher
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 300 points on Friday. The Dow traded down 1.07% to 31,899.93 while the NASDAQ fell 0.68% to 11,638.13. The S&P... 
Via Benzinga
Why Is Diebold Nixdorf (DBD) Stock Down 42% Today?
Diebold Nixdorf (DBD) stock is taking a beating on Friday after the company released its annual shareholder letter for 2022. 
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
The biggest pre-market stock movers for Friday are ready to go as we dive into the latest news for investors this morning! 
Via InvestorPlace
Why Sarepta Therapeutics Shares Are Trading Lower By Around 19%; Here Are 20 Stocks Moving Premarket
Gainers Enzo Biochem, Inc. (NYSE: ENZ) shares rose 89.9% to $2.26 in pre-market trading after the company announced it will sell its clinical laboratory to Labcorp. 
Via Benzinga
Why Enzo Biochem Stock Is Skyrocketing After Hours
Enzo Biochem Inc (NYSE: ENZ) shares are soaring in extended trading Thursday after the company agreed to sell its clinical lab to Laboratory Corporation Of America 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp
From Enzo Biochem, Inc.
Via GlobeNewswire
Tenaya Therapeutics, Clear Channel Outdoor And These 2 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower for the third straight session on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and... 
Via Benzinga
Myomo, Enzo Biochem And These 2 Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed lower by more than 600 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Nasdaq Rises 100 Points; Gold Gains Over 1%
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining 100 points on Tuesday 
Via Benzinga
Dow Turns Lower; Crude Oil Rises Sharply
U.S. stocks pared gains midway through trading, with the Dow Jones turning lower on Tuesday 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 49 companies hit new 52-week lows. 
Via Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial. 
Via Benzinga
Earnings Scheduled For December 12, 2022
Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is projected to report earnings for its second quarter. 
Via Benzinga
Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th
From Enzo Biochem, Inc.
Via GlobeNewswire
Enzo Biochem, Inc. Announces Date of Annual Shareholders’ Meeting
From Enzo Biochem, Inc.
Via GlobeNewswire
Farmer Bros. Co. Announces Board Refresh and Cooperation Agreement with Stockholders JCP Investment Management and 22NW
From Farmer Bros. Co.
Via GlobeNewswire
Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO
- David Bench resigning to pursue a new career opportunity - 
From Enzo Biochem, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.